Howard Schneiderman

Howard A. Schneiderman, 63, chief scientist and senior vice president of the St. Louis-based Monsanto Co., died December 5 of complications associated with leukemia. Schneiderman came to Monsanto in 1979 from the University of California, Irvine, where he was dean of the school of biological sciences and director of the Center for Pathobiology. He conducted research in developmental biology and genetics, including growth control, congenital malformations, and cancer. Under Schneiderman's direc

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Howard A. Schneiderman, 63, chief scientist and senior vice president of the St. Louis-based Monsanto Co., died December 5 of complications associated with leukemia. Schneiderman came to Monsanto in 1979 from the University of California, Irvine, where he was dean of the school of biological sciences and director of the Center for Pathobiology. He conducted research in developmental biology and genetics, including growth control, congenital malformations, and cancer. Under Schneiderman's direction at Monsanto, the company built the Life Sciences Research Center for biotechnology research in Chesterfield, Mo., and established collaborative research products with several universities. Schneiderman graduated from Swarthmore College in 19TK. He earned a master's degree in zoology in 19TK and a doctorate in physiology in 19TK from Harvard University. He was a member of the National Science Board, the American Academy of Arts and Sciences, and the National Academy of Sciences' Council of the Government-University-Industry Research Roundtable.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies